113.64

0.18% -0.115

Repligen Corp (RGEN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RGEN? Forum Prognose

Schlusskurs vom Vortag:

$113.76

Offen:

$114.5

24-Stunden-Volumen:

475.14K

Relative Volume:

0.65

Marktkapitalisierung:

$6.40B

Einnahmen:

$633.51M

Nettoeinkommen (Verlust:

$-8.10M

KGV:

-366.60

EPS:

-0.31

Netto-Cashflow:

$131.26M

1W Leistung:

-5.36%

1M Leistung:

-16.77%

6M Leistung:

+0.02%

1J Leistung:

-20.27%

1-Tages-Spanne:

$112.83

$116.01

1-Wochen-Bereich:

$112.47

$129.00

52-Wochen-Spanne:

$102.97

$175.77

Repligen Corp Stock (RGEN) Company Profile

Firmenname

Repligen Corp

Sektor

Healthcare (1118)

Branche

Medical Instruments & Supplies (58)

Telefon

(781) 449-9560

Adresse

41 SEYON STREET, WALTHAM, MA

Mitarbeiter

2,000

Twitter

@repligen

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RGEN Repligen Corp	113.64	6.41B	633.51M	-8.10M	131.26M	-0.31
ISRG Intuitive Surgical Inc	474.28	170.20B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	160.84	45.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.08	38.26B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	231.16	33.86B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	41.21	33.33B	28.43B	1.16B	1.26B	1.4457

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-01	Eingeleitet	HSBC Securities	Buy
2025-09-22	Hochstufung	Evercore ISI	In-line → Outperform
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-06-24	Eingeleitet	Barclays	Overweight
2025-04-29	Hochstufung	Wolfe Research	Peer Perform → Outperform
2025-03-18	Eingeleitet	Evercore ISI	In-line
2025-02-10	Eingeleitet	TD Cowen	Buy
2024-12-17	Eingeleitet	Canaccord Genuity	Hold
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-26	Hochstufung	Deutsche Bank	Hold → Buy
2024-06-18	Eingeleitet	Guggenheim	Neutral
2023-12-04	Herabstufung	The Benchmark Company	Buy → Hold
2023-07-20	Eingeleitet	Wells Fargo	Overweight
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-03-28	Eingeleitet	The Benchmark Company	Buy
2022-12-14	Eingeleitet	Deutsche Bank	Hold
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-07-20	Eingeleitet	UBS	Buy
2021-10-14	Eingeleitet	Exane BNP Paribas	Outperform
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-08-24	Bestätigt	H.C. Wainwright	Buy
2020-06-30	Bestätigt	H.C. Wainwright	Buy
2020-05-07	Bestätigt	H.C. Wainwright	Buy
2020-03-23	Bestätigt	H.C. Wainwright	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-11-01	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-10-15	Eingeleitet	SVB Leerink	Outperform
2019-08-28	Bestätigt	First Analysis Sec	Outperform
2019-08-23	Fortgesetzt	Stephens	Overweight
2019-07-22	Hochstufung	H.C. Wainwright	Neutral → Buy
2018-12-17	Hochstufung	CL King	Neutral → Buy
2018-11-12	Herabstufung	CL King	Buy → Neutral
2018-09-26	Eingeleitet	H.C. Wainwright	Neutral
2017-12-08	Eingeleitet	Citigroup	Buy
2017-12-05	Eingeleitet	JP Morgan	Overweight
2017-11-13	Eingeleitet	CL King	Buy
2017-10-02	Hochstufung	First Analysis Sec	Equal-Weight → Overweight
2017-07-21	Eingeleitet	William Blair	Outperform
2017-02-13	Hochstufung	Piper Jaffray	Neutral → Overweight

Alle ansehen

Repligen Corp Aktie (RGEN) Neueste Nachrichten

Mar 11, 2026

Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 11, 2026

Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat

Mar 11, 2026

Mar 10, 2026

Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com

Mar 10, 2026

Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance

Mar 08, 2026

Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance

Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st

Mar 08, 2026

Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 08, 2026

Mar 06, 2026

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 06, 2026

Mar 05, 2026

NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat

Mar 04, 2026

Mar 03, 2026

Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan

Mar 03, 2026

Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan

Mar 03, 2026

Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan

Mar 03, 2026

Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan

Mar 03, 2026

Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan

Mar 03, 2026

Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan

Mar 03, 2026

Mar 02, 2026

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews

Mar 02, 2026

Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat

Mar 02, 2026

3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Finviz

Mar 02, 2026

Mar 01, 2026

Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat

Mar 01, 2026

Feb 28, 2026

Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat

Feb 28, 2026

Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Feb 28, 2026

Feb 27, 2026

Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance

Feb 27, 2026